Introduction
The secretion of a hormone with insulin-like activity by hepatic metastases is an uncommon complication of non-pancreatic malignant tumours (Laurent, Debry and Floquet, 1971 (Athanasoulis, 1980) (Fig. 2) . Following this procedure right hypochondrial pain and fever persisted for 5 days. The patient had no further hypoglycaemic attacks and was discharged home 6 days after embolization.
Recurrence of hypoglycaemic episodes occurred in January, April, August and October 1980. On each occasion trans-catheter hepatic arterial embolization was repeated under local anaesthesia with complete relief of hypoglycaemic symptoms and a characteristic febrile and hepatic pain response lasting for 5 days. Hepatic arteriography carried out before embolization revealed partial recanalization of the previously completely occluded hepatic arterial supply and recurrence of highly vascular deposits. The embolic materials used were gelatine sponge, prepared human dura and wire coils with dacron threads (Gianturco, Anderson and Wallace, 1975) . Hormone studies during hypoglycaemic episodes suggested that the metastatic tumour was secreting hormones with insulin-like activity. This was exemplified by a plasma glucose of 1.5 mmol/l (normal range, 3-6-5-8 mmol/l) associated with a plasma insulin of 0.6 mu./l (normal range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] mu./l) and a plasma C-peptide level of 0.2 nmol/l (normal range, 0-2-069 nmol/l). Plasma gastrin, vasoactive intestinal polypeptide and somatostatin were normal. After each embolization the patient became free of hypoglycaemic episodes and returned to work.
Discussion
In the management of hormone secreting metastases throughout both lobes of the liver, the role of surgery, radiotherapy and chemotherapy is limited (Allison, Modun and Jenkins, 1977 (Allison et al., 1977; Allison, 1978) but this is thought to be the first report of non-pancreatic liver tumour with insulin-like activity effectively controlled by embolization.
